Eagle Pharmaceuticals
NAS:EGRX
Pharmaceuticals: Other
—
SMALL cap
(—)
—
since start of 2022
—
About
Pharmaceuticals: OtherFounded 2007
Eagle Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the provision of injectable products. Its activities include development and commercialization of pharmaceutical products for the treatment of areas such as critical care, orphan diseases, and oncology. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Headquarters
Executives
Name | Title | Gender |
Scott L. Tarriff, MBA | Chief Executive Officer & Director | Male |
Peter E. Grebow, PhD | Executive Vice President-Research & Development | Male |
David E. Riggs, MBA | Chief Financial Officer | Male |
David M. Pernock | President & Chief Commercial Officer | Male |
Adrian Hepner, MD, PhD | Executive Vice President & Chief Medical Officer | Male |
Michael Graves | Chairman | Male |
Steven L. Krill, PhD | Chief Scientific Officer & Executive VP | Male |
John LaRocca | Chief Compliance Officer, EVP & General Counsel | Male |
Mindful Investing Summary
Eagle Pharmaceuticals - Competitors and Related Companies
How Eagle Pharmaceuticals stacks up to its peers in thePharmaceuticals: Other industry or with competing business segments.
Eagle Pharmaceuticals
NAS:EGRX
Pharmaceuticals: Other
—
SMALL cap
(—)
—
since start of 2022
—
Madrigal Pharmaceuticals
NAS:MDGL
Pharmaceuticals: Other
—
SMALL cap
(—)
—
since start of 2022
—
Bristol-Myers Squibb
NYS:BMY
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Eli Lilly
NYS:LLY
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Johnson & Johnson
NYS:JNJ
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Novartis
SWX:NOVN-CH
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—